Abstract CT015: Safety and long-term efficacy of radioligand therapy using Lu-177 labeled PSMA ligands in metastatic prostate cancer: A single center experience over 5 years
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 2008
◽
pp. 295-296